832715-99-8 Usage
Uses
Used in Coordination Chemistry:
6-tert-butylnicotinic acid is used as a ligand in coordination chemistry for its ability to form stable complexes with various metal ions. This application is crucial for the development of new materials with specific properties and potential applications in catalysis, sensors, and other fields.
Used in Pharmaceutical Industry:
6-tert-butylnicotinic acid is used as a precursor for the synthesis of various pharmaceutical compounds due to its unique molecular structure and functional properties. Its antioxidant and anti-inflammatory properties make it a potential candidate for the development of new therapeutic agents targeting a wide range of diseases and conditions.
Used in Agrochemical Industry:
6-tert-butylnicotinic acid is used as a precursor for the synthesis of agrochemicals, contributing to the development of new pesticides, herbicides, and other agricultural chemicals. Its unique properties can potentially enhance the effectiveness and selectivity of these compounds, leading to improved crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 832715-99-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,3,2,7,1 and 5 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 832715-99:
(8*8)+(7*3)+(6*2)+(5*7)+(4*1)+(3*5)+(2*9)+(1*9)=178
178 % 10 = 8
So 832715-99-8 is a valid CAS Registry Number.
832715-99-8Relevant articles and documents
THIAZOLE DERIVATIVES AS INHIBITORS OF BRUTON'S TYROSINE KINASE
-
Page/Page column 45, (2014/07/07)
This application discloses compounds according to generic Formula I: wherein all variables are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with exc
INHIBITORS OF BRUTON'S TYROSINE KINASE
-
Page/Page column 104; 105, (2014/05/24)
This application discloses compounds according to generic Formula I: wherein all variables are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with exc
KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS
-
Page/Page column 206, (2008/06/13)
Methods of inhibiting BTK activity by inhibiting phosphorylation of Y551 of BTK, methods of treating patients by inhibiting BTK activity by inhibiting phosphorylation of Y551 of BTK, chemical entities that bind to BTK and inhibited complexes are provided.
FUSED-ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO
-
Page 229, (2008/06/13)
The present invention relates to certain fused aryl and heteroaryl derivatives of Formula (I) that are modulators of metabolism. Accordingly, compounds of the present invention are useful in the prophylaxis or treatment of metabolic disorders and complica
